Homepage Top Section2

The companies are also launching their first collaboratively developed product, Aridol, and plan to introduce further branded products in the future. The collaboration integrates Arna Pharma’s development expertise

With this authorisation, the UAE is said to become the first nation worldwide to approve this treatment, which is offered in 1mg and 2mg doses. This move underscores

The move leverages CTTQ’s extensive reach and portfolio in liver disease, covering more than 5,000 medical centres in China. Under this agreement, the company will manage the importation,

The upgrade focuses on providing a unified and accessible framework, eliminating redundant review steps and supporting drug discovery and development projects. With this updated licensing policy, customers have

The location will serve as Novartis’ first RLT manufacturing site in Texas and is the company’s fifth such site in the country, increasing supply chain reach for the

Waiv will use its computational pathology platform to work with early phase data, which will involve analysis of tumour microenvironments using haematoxylin and eosin (H&E), as well as

The therapy is approved by the US Food and Drug Administration (FDA) for adult patients with relapsed or refractory Stage I-III cutaneous T-cell lymphoma (CTCL) following at least one prior systemic treatment. The

Langlara is cleared for use in adults and children with type 1 diabetes mellitus (T1DM), as well as adults with type 2 diabetes mellitus (T2DM). The FDA’s decision

The therapy is approved as an add-on to diet, specifically for adults with FCS whose triglyceride levels remain high despite standard triglyceride-lowering treatments. The approval marks an expansion